These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6140299)

  • 1. Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug.
    McMillen BA; Mattiace LA
    J Neural Transm; 1983; 57(4):255-65. PubMed ID: 6140299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat.
    McMillen BA; McDonald CC
    Neuropharmacology; 1983 Mar; 22(3):273-8. PubMed ID: 6133232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor antagonism by the novel antianxiety drug, buspirone.
    McMillen BA; Matthews RT; Sanghera MK; Shepard PD; German DC
    J Neurosci; 1983 Apr; 3(4):733-8. PubMed ID: 6131948
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
    McMillen BA
    J Neural Transm; 1985; 64(1):1-12. PubMed ID: 2866230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.
    Meltzer HY; Simonovic M; Fang VS; Gudelsky GA
    Psychopharmacology (Berl); 1982; 78(1):49-53. PubMed ID: 6128756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT; McMillen BA; Sallis R; Blair D
    J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone analogues. 2. Structure-activity relationships of aromatic imide derivatives.
    New JS; Yevich JP; Eison MS; Taylor DP; Eison AS; Riblet LA; VanderMaelen CP; Temple DL
    J Med Chem; 1986 Aug; 29(8):1476-82. PubMed ID: 2874226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic control of dopamine metabolism in the nucleus accumbens. Lack of effect of buspirone as demonstrated using in vivo voltammetry.
    Louilot A; Le Moal M; Simon H
    Life Sci; 1987 May; 40(20):2017-24. PubMed ID: 3573992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the effects of buspirone, BMY 13805, and 1-PP on dopaminergic metabolism in the nucleus accumbens using in vivo voltammetry in freely moving rats.
    Louilot A; Le Moal M; Simon H
    Life Sci; 1986 Aug; 39(8):685-92. PubMed ID: 2874469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notes on buspirone's mechanisms of action.
    Garattini S; Caccia S; Mennini T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats].
    Bogdanov MB; Gaĭnetdinov RR; Kudrin VS; Medvedev OS; Val'dman AV
    Biull Eksp Biol Med; 1991 May; 111(5):505-7. PubMed ID: 1715214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system.
    Kolasa K; Fusi R; Garattini S; Consolo S; Ladinsky H
    J Pharm Pharmacol; 1982 May; 34(5):314-7. PubMed ID: 6123570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic effects of buspirone, a novel anxiolytic agent.
    Cimino M; Ponzio F; Achilli G; Vantini G; Perego C; Algeri S; Garattini S
    Biochem Pharmacol; 1983 Mar; 32(6):1069-74. PubMed ID: 6838654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent response of central dopaminergic systems to buspirone in mice.
    Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Gursale SC; Balsara JJ
    Indian J Exp Biol; 2008 Oct; 46(10):704-14. PubMed ID: 19024168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA
    Biochem Pharmacol; 1982 Aug; 31(16):2643-7. PubMed ID: 6128002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarized striatal dopaminergic terminals.
    el Mestikawy S; Glowinski J; Hamon M
    J Neurochem; 1986 Jan; 46(1):12-22. PubMed ID: 2866232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.